Tellimer logo
Search icon
Equity Analysis
/United States of America

US : argenx SE - ARGX | R&D Day Focus: Efgar's New Indications Myositis & Bullous Pemphigoid, ARGX-117 Ph 1 Data

    Danielle Brill
    20 July 2021
    Published by


    Tellimer | Start Following

    Start following your markets today

    Follow your key analysts, markets and more so they appear here in your Watchlist - allowing you to keep an eye on the latest updates.